Journal of Shandong University (Health Sciences) ›› 2023, Vol. 61 ›› Issue (4): 86-94.doi: 10.6040/j.issn.1671-7554.0.2022.0927
• 公共卫生与管理学 • Previous Articles
ZHONG Lu1,2, XUE Fuzhong1,2
CLC Number:
| [1] 邱海波, 曹素梅, 徐瑞华. 基于2020年全球流行病学数据分析中国癌症发病率、死亡率和负担的时间趋势及与美国和英国数据的比较[J]. 癌症, 2022, 41(4): 165-177. QIU Haibo, CAO Sumei, XU Ruihua. Temporal trends of cancer incidence, mortality and burden in China based on global epidemiological data in 2020 and comparison with data from the United States and the United Kingdom[J]. Cancer, 2022, 41(4): 165-177. [2] De Groot PM, Wu CC, Carter BW, et al. The epidemiology of lung cancer[J]. Transl Lung Cancer Res, 2018, 7(3): 220-233. [3] 李玲燕, 袁萍. 53例肺癌放疗患者生存质量分析[J]. 解放军预防医学杂志, 2018, 36(12): 1592-1596. LI Lingyan, YUAN Ping. Quality of life analysis of 53 patients with lung cancer radiotherapy[J]. PLA Preventive Medicine Journal, 2018, 36(12): 1592-1596. [4] 袁冬梅, 宋勇. 非小细胞肺癌治疗新时代:免疫治疗[J]. 解放军医学杂志, 2017, 42(6): 483-487. YUAN Dongmei, SONG Yong. Non-small cell lung cancer: a new era of immunotherapy[J]. PLA Medical Journal, 2017, 42(6): 483-487. [5] Cox DR. Regression models and life-tables[J]. J R STAT SOC: Series B(Methodological), 1972, 34(2): 187-202. [6] 吕章艳, 谭锋维, 林春青, 等. 肺癌风险预测模型构建与验证的系统综述[J]. 中华预防医学杂志, 2020(4): 430-437. doi: 10.3760/cma.j.cn112150-20190523-00415. LYU Zhangyan, TAN Fengwei, LIN Chunqing, et al. Lung cancer risk prediction model construction and validation: a systematic review[J]. Chinese Journal of Preventive Medicine, 2020(4): 430-437. doi: 10.3760/cma.j.cn112150-20190523-00415. [7] Burton A, Altman D. Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines[J]. Br J Cancer, 2004, 91(1): 4-8. [8] Suthar B, Patel H, Goswami A. A survey: classification of imputation methods in data mining[J]. IJETAE, 2012, 2(1): 309-312. [9] Van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis[J]. Stat Med, 1999, 18(6): 681-694. [10] Waljee AK, Mukherjee A, Singal AG, et al. Comparison of imputation methods for missing laboratory data in medicine[J]. BMJ Open, 2013, 3(8): e002847. doi:10.1136/bmjopen-2013-002847. [11] Jensen FV, Nielsen TD. Bayesian networks and decision graphs [M]. New York: Springer, 2007. [12] Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data[J]. Nature, 2018, 562(7726): 203-209. [13] Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective[J]. Proc Nutr Soc, 2008, 67(3): 253-256. [14] Biedermann A, Taroni F. Bayesian networks and probabilistic reasoning about scientific evidence when there is a lack of data[J]. Forensic Sci Int, 2006, 157(2-3): 163-167. [15] Larranaga P, Karshenas H, Bielza C, et al. A review on evolutionary algorithms in Bayesian network learning and inference tasks[J]. INS, 2013, 233: 109-125. doi:10.1016/j.ins.2012.12.051. [16] Glover F. Artificial intelligence, heuristic frameworks and tabu search[J]. Manag Decis Econ, 1990, 11(5): 365-375. [17] Peng Y, Zhang S, Pan R. Bayesian network reasoning with uncertain evidences[J]. Int J Uncertain Fuzz, 2010, 18(5): 539-564. [18] 于汉成, 张霁娟, 刘峰, 等. 基于纵向健康体检数据的高尿酸血症发病风险预测模型[J]. 现代预防医学, 2021, 48(23): 4408-4412. YU Hancheng, ZHANG Jijuan, LIU Feng, et al. Risk prediction model of hyperuricemia based on longitudinal health examination data[J]. Mod Prev Med, 2021, 48(23): 4408-4412. [19] 李迪, 段书音, 何霞霞, 等. 基于logistic回归的肺癌危险度评价模型的构建[J]. 郑州大学学报(医学版), 2019, 54(6): 832-834. LI Di, DUAN Shuyin, HE Xiaxia, et al. Construction of risk assessment model for lung cancer based on logistic regression[J]. Journal of Zhengzhou University(Medical Sciences), 2019, 54(6): 832-834. [20] Okeeffe LM, Taylor G, Huxley RR, et al. Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis[J]. BMJ Open, 2018, 8(10): e021611. doi:10.1136/bmjopen-2018-021611. [21] 阮晓楠, 吕桦, 杨黎明, 等. 上海市浦东新区肺癌病例对照研究[J]. 中国肿瘤, 2011, 20(12): 885-888. RUAN Xiaonan, LYU Hua, YANG Liming, et al. Case control study of lung cancer in Pudong New Area of Shanghai[J]. China Cancer, 2011, 20(12): 885-888. [22] 孙鑫, 覃文进, 刘理礼,等. 肺癌发病危险因素最新研究进展[J]. 现代肿瘤医学, 2022, 30(4): 753-756. SUN Xin, QIN Wenjin, LIU Lili, et al. Recent research progress in risk factors of lung cancer[J]. Journal of Modern Oncology, 2022, 30(4): 753-756. [23] Huang Y, Zhu M, Ji M, et al. Air pollution, genetic factors, and the risk of lung cancer: a prospective study in the UK Biobank[J]. Am J Respir Crit Care Med, 2021, 204(7): 817-825. [24] Biedermann A, Taroni F. Bayesian networks and probabilistic reasoning about scientific evidence when there is a lack of data[J]. Forensic Sci Int, 2006, 157(2-3): 163-167. [25] Chen J, Zhang R, Dong X, et al. shinyBN: an online application for interactive Bayesian network inference and visualization[J]. BMC Bioinformatics, 2019, 20(1): 711. doi:10.1186/s12859-019-3309-0. |
| [1] | YANG Yongqing, ZHAO Peng, WANG Yu, MA Wenjing, TIAN Mimi, CHENG Yani, ZU Lu, LIN Xiangtao. Diagnostic value of extracellular volume fraction in 62 cases of different pathological types of lung cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(2): 88-94. |
| [2] | HAN Jing, JIA Chunling. Effects of periodontal basic therapy on postoperative pneumonia in patients with lung cancer before thoracic surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 113-118. |
| [3] | GAO Zhongxia, ZHANG Ming, FAN Mingde, TAN Chenyang, WANG Mengdi, WANG Chao, FAN Yuefei, DING Shouluan, WANG Chengwei. Efficacy and prognostic factors of gamma knife in treating 81 cases of brain metastases from lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 44-49. |
| [4] | WANG Fuli, SUN Yinping, QIN Jie, RONG Jiansheng. Efficacy of DC-CIK cells combined with EGFR-TKI for 35 elderly patients with advanced EGFR-mutant lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 110-117. |
| [5] | QIN Jing, YANG Fei, CHEN Qian, XIA Handai, LIU Yanguo, WANG Xiuwen. A network meta-analysis of first-line treatment options for patients with advanced driver-gene wild-type and PD-L1 negative non-squamous non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 74-82. |
| [6] | CHEN Zhaobo, FANG Min, XUE Haoran, LIU Chunyan. Deubiquitinase USP35 promotes the cells migration and invasion of non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 30-37. |
| [7] | MA Ruijie, ZHU Liangming, ZUO Taiyang, LI Chunhai, ZHANG Nan, SUN Zhigang. Prognosis of microwave ablation for pulmonary oligometastases after radical resection of non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(12): 63-68. |
| [8] | Shugeng GAO. Application of enhanced recovery after surgery in perioperative management of lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 1-10. |
| [9] | Dingpei HAN,Yue YAN,Yuqin CAO,Xin SUN,Yanxia HU,Minxian WANG,Yan LUO,Yongmei SHI,Qing XIE,Junbiao HANG,Hecheng LI. Expert consensus of Ruijin Hospital on the concept of enhanced recovery after surgery in the clinical practice of thoracic surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 11-16. |
| [10] | Huining LIU,Jun PENG,Yingchun REN,Guang YANG,Wenhao WANG,Jinfeng LIU,Qing TIAN. Comparison of 34 cases of thoracoscopic wedge resection and 21 cases of segmental resection for stage ⅠA1 non-small cell lung cancer in area P [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 38-43. |
| [11] | Yue PENG,Lei LIU,Yuan LI,Fenglong BIE,Bolun ZHOU,Runze LI,Ying JI,Guangyu BAI,Fengwei TAN,Yushun GAO,Juwei MU,Qi XUE,Bin QIU,Shugeng GAO. Comprehensive application of anatomical partial lobectomy and enhanced recovery after surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 44-53. |
| [12] | Huijiang GAO,Yucheng WEI. Minimally invasive sleeve lobectomy: opportunities and challenges in the era of immunotherapy [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 23-27. |
| [13] | DING Zichen, WANG Haohua, ZHOU Liwen, CONG Huiwen, LI Chengsheng, BAO Qihan, YANG Yi, WANG Lianyuan, WANG Suzhen, SHI Fuyan. Study on the individualized efficacy for non-small cell lung cancer patients based on Bayesian Additive Regression Tree model [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 92-98. |
| [14] | YU Jinming, YAN Weiwei, CHEN Dawei. New practice of radio-immunotherapy for lung cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 1-8. |
| [15] | ZHANG Xiqin, ZHU Shouhui, LIU Ning, WANG Yu, CHEN Jiazhen, HU Xudong. Clinical observation of PEG-rhG-CSF in preventing neutropenia in 80 patients with small cell lung cancer treated with concurrent chemoradiotherapy [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 43-46. |
|
||